1. Home
  2. PRDO vs MPLT Comparison

PRDO vs MPLT Comparison

Compare PRDO & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perdoceo Education Corporation

PRDO

Perdoceo Education Corporation

HOLD

Current Price

$32.75

Market Cap

2.0B

Sector

Real Estate

ML Signal

HOLD

Logo MapLight Therapeutics Inc.

MPLT

MapLight Therapeutics Inc.

HOLD

Current Price

$10.69

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRDO
MPLT
Founded
1994
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.7B
IPO Year
1997
2025

Fundamental Metrics

Financial Performance
Metric
PRDO
MPLT
Price
$32.75
$10.69
Analyst Decision
Buy
Strong Buy
Analyst Count
1
7
Target Price
$42.00
$32.67
AVG Volume (30 Days)
442.5K
527.9K
Earning Date
05-07-2026
05-28-2026
Dividend Yield
1.75%
N/A
EPS Growth
10.50
82.39
EPS
1.60
N/A
Revenue
$581,296,000.00
N/A
Revenue This Year
$4.28
N/A
Revenue Next Year
$2.89
N/A
P/E Ratio
$20.46
N/A
Revenue Growth
N/A
N/A
52 Week Low
$26.66
$9.10
52 Week High
$38.50
$40.43

Technical Indicators

Market Signals
Indicator
PRDO
MPLT
Relative Strength Index (RSI) 48.07 30.35
Support Level $31.32 $9.10
Resistance Level $32.79 $20.20
Average True Range (ATR) 0.92 0.93
MACD -0.06 0.16
Stochastic Oscillator 41.91 2.43

Price Performance

Historical Comparison
PRDO
MPLT

About PRDO Perdoceo Education Corporation

Perdoceo Education Corp is an American for-profit education company that focuses on quality postsecondary education online to a diverse student population, along with campus-based and blended learning programs. The company's important segments include the American InterContinental University, the University of St. Augustine for Health Sciences, and Colorado Technical University. These universities provide undergraduate, graduate, and doctoral degree programs focusing on business, technology, management, and social services, with the majority of the students enrolled in programs offered fully online. The majority of the its revenue comes from the Colorado Technical University segment.

About MPLT MapLight Therapeutics Inc.

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.

Share on Social Networks: